跳至主要内容
临床试验/ISRCTN76049483
ISRCTN76049483已完成不适用

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells in patients with advanced limb ischaemia

eiden University Medical Centre (LUMC) (The Netherlands)0 个研究点目标入组 25 人开始时间: 2007年7月16日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Disabling claudication (Fontaine?s stages IIb/III or Rutherford?s categories 3/4) or critical limb ischaemia (Fontaine?s stages IV or Rutherford?s categories 5/6) despite greater than six months optimal medical therapy
  • 2. Ineligibility for angioplasty or bypass procedures
  • 3. Male of female, greater than 18 years old
  • 4. Life expectancy greater than one year
  • 5. Written informed consent

排除标准

  • 1. Candidates for angioplasty or bypass procedures
  • 2. Inability to undergo bone marrow harvesting
  • 3. Life threatening co-morbidity
  • 4. International Normalised Ratio (INR) greater than 2
  • 5. History of malignant disease in five years prior to treatment
  • 6. Inability to undergo arterial catheterisation
  • 7. Inability to follow the protocol and to comply with the follow up requirements
  • 8. Any other conditions that, in the opinion of the investigators, could interfere with the therapy or could pose a significant threat to the subject if the investigational therapy was to be initiated

研究者

发起方
eiden University Medical Centre (LUMC) (The Netherlands)

相似试验